Sophia Genetics Affirms FY2026 Sales Guidance of $92.000M-$94.000M vs $93.250M Est

Benzinga Newsdesk www.benzinga.com Negative 79.7%

Neg 79.7% Neu 0% Pos 0%

Sophia Genetics (NASDAQ:SOPH) affirms FY2026 sales outlook from $92.000 million-$94.000 million to $92.000 million-$94.000 million vs $93.250 million estimate.